Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-16

Clinical Trial Update: Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of givinostat for Polyarticular Juvenile Idiopathic Arthritis was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Polyarticular Course Juvenile Idiopathic Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-04-16